| scholarly article | Q13442814 |
| P50 | author | Erick Moran Carreira | Q15990405 |
| Paul Kellam | Q24005990 | ||
| Tsai-Yu Lin | Q38319209 | ||
| David Sarlah | Q53814393 | ||
| P2093 | author name string | Abraham L Brass | |
| George Savidis | |||
| Simon Clare | |||
| Stephen J Elledge | |||
| Christopher R Chin | |||
| Sinu P John | |||
| Jill M Perreira | |||
| Aaron R Everitt | |||
| Aaron M Aker | |||
| P2860 | cites work | IFITM3 inhibits influenza A virus infection by preventing cytosolic entry | Q21090493 |
| IFITM proteins restrict viral membrane hemifusion | Q21558779 | ||
| Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms | Q24302747 | ||
| Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus | Q24337838 | ||
| IFITM3 restricts the morbidity and mortality associated with influenza | Q24369689 | ||
| A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 | ||
| The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus | Q24645420 | ||
| Ifitm3 limits the severity of acute influenza in mice | Q27342563 | ||
| Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses | Q27482329 | ||
| A class of membrane proteins shaping the tubular endoplasmic reticulum | Q27940194 | ||
| Influenza A viruses: new research developments | Q30404670 | ||
| Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals | Q30426474 | ||
| Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections | Q34046037 | ||
| Vesicle-associated membrane protein-associated protein-A (VAP-A) interacts with the oxysterol-binding protein to modify export from the endoplasmic reticulum. | Q34129670 | ||
| The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry | Q34340346 | ||
| Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections | Q34960317 | ||
| Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture | Q35363496 | ||
| S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus | Q36003903 | ||
| Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion | Q36303032 | ||
| On the one-sided action of amphotericin B on lipid bilayer membranes | Q36415709 | ||
| Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. | Q36626209 | ||
| The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication | Q36978590 | ||
| IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus | Q37036679 | ||
| Clinical pharmacokinetics of systemically administered antimycotics. | Q37239121 | ||
| Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH. | Q37817875 | ||
| Functional relevance of transmembrane domains in membrane fusion | Q38056472 | ||
| The broad-spectrum antiviral functions of IFIT and IFITM proteins | Q38067210 | ||
| IFITMs restrict the replication of multiple pathogenic viruses | Q38146443 | ||
| Membrane effects of the polyene antibiotic amphotericin B and of some of its derivatives on lymphocytes | Q38766534 | ||
| Amphotericin B resistance and membrane fluidity in Kluyveromyces lactis strains | Q39474435 | ||
| How do the polyene macrolide antibiotics affect the cellular membrane properties? | Q39750989 | ||
| Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox. | Q40538343 | ||
| IFITM1 is a tight junction protein that inhibits hepatitis C virus entry | Q41844055 | ||
| Structural characterization of the caveolin scaffolding domain in association with cholesterol-rich membranes. | Q42621806 | ||
| Modulatory action of acetylcholine on the Na+-dependent action potentials in Kenyon cells isolated from the mushroom body of the cricket brain | Q42967967 | ||
| Active amphotericin B derivatives position the mycosamine in two radial orientations | Q43135879 | ||
| Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function | Q43415353 | ||
| Enhanced survival of lung tissue-resident memory CD8⁺ T cells during infection with influenza virus due to selective expression of IFITM3. | Q44756592 | ||
| Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion | Q45794186 | ||
| Effects of monovalent cations on Semliki Forest virus entry into BHK-21 cells | Q45828150 | ||
| Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B. | Q46807515 | ||
| Perturbation of the fluidity of the erythrocyte membrane with ionophoric antibiotics and lipophilic anaesthetics | Q51704303 | ||
| Membrane Fission: Curvature-Sensitive Proteins Cut It Both Ways | Q60456130 | ||
| Identification of the structural elements of amphotericin B and other polyene macrolide antibiotics of the hepteane group influencing the ionic selectivity of the permeability pathways formed in the red cell membrane | Q70836746 | ||
| Na+, K+ and Cl- selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics | Q72106644 | ||
| P433 | issue | 4 | |
| P921 | main subject | amphotericin B | Q412223 |
| influenza A virus | Q834390 | ||
| P304 | page(s) | 895-908 | |
| P577 | publication date | 2013-11-21 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction | |
| P478 | volume | 5 |
| Q37028086 | A Role for IFITM Proteins in Restriction of Mycobacterium tuberculosis Infection |
| Q35221778 | A membrane topology model for human interferon inducible transmembrane protein 1. |
| Q35080316 | A sorting signal suppresses IFITM1 restriction of viral entry |
| Q27317296 | ADAP2 Is an Interferon Stimulated Gene That Restricts RNA Virus Entry |
| Q92527731 | Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay |
| Q63246712 | Antiviral Protection by IFITM3 In Vivo |
| Q26748091 | Fever as an important resource for infectious diseases research |
| Q57043865 | From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections |
| Q64989066 | Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity. |
| Q57792998 | Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the Interferon-Induced Transmembrane Protein 3 (IFITM3) against HIV-1 |
| Q90616762 | HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3 |
| Q30375716 | Host genes and influenza pathogenesis in humans: an emerging paradigm. |
| Q36825419 | Human, Pig, and Mouse Interferon-Induced Transmembrane Proteins Partially Restrict Pseudotyped Lentiviral Vectors |
| Q61450240 | IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections |
| Q36150469 | IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. |
| Q40181638 | IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity |
| Q38933130 | IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. |
| Q38953321 | IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms |
| Q41749794 | IFITM, a common barrier to many viruses |
| Q38323041 | IFITM-Family Proteins: The Cell's First Line of Antiviral Defense |
| Q38637849 | IFITM1 suppresses expression of human endogenous retroviruses in human embryonic stem cells |
| Q57185105 | IFITM3 Restricts Human Metapneumovirus Infection |
| Q92882121 | IFITM3 protects the heart during influenza virus infection |
| Q38156590 | IFITM3 requires an amphipathic helix for antiviral activity. |
| Q27329190 | IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion |
| Q35808675 | IFITMs from Mycobacteria Confer Resistance to Influenza Virus When Expressed in Human Cells. |
| Q47269172 | Identification of residues controlling restriction versus enhancing activities of IFITM proteins on the entry of human coronaviruses |
| Q47550785 | Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane |
| Q41928655 | Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs |
| Q33606757 | Interferon induction of IFITM proteins promotes infection by human coronavirus OC43 |
| Q36043274 | Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses |
| Q91813039 | Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection |
| Q61818410 | Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes |
| Q59356088 | Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus |
| Q38206867 | Mitigation of human-pathogenic fungi that exhibit resistance to medical agents: can clinical antifungal stewardship help? |
| Q46197224 | More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins |
| Q40469216 | Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. |
| Q39027209 | Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis. |
| Q36039523 | Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV. |
| Q38792678 | Polyene macrolide biosynthesis in streptomycetes and related bacteria: recent advances from genome sequencing and experimental studies |
| Q36090006 | Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. |
| Q34627384 | Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications. |
| Q37359047 | Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction. |
| Q24367663 | The IFITMs Inhibit Zika Virus Replication |
| Q37252899 | The Interferon-Stimulated Gene IFITM3 Restricts Infection and Pathogenesis of Arthritogenic and Encephalitic Alphaviruses |
| Q64227333 | The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo |
| Q107473210 | The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets |
| Q106873636 | The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells |
| Q47592878 | The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity |
| Q30400470 | pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs |
Search more.